ProPublica

Journalism in the Public Interest

Cancel

Ryann Grochowski Jones

Ryann Grochowski Jones

Contact Info

Get Updates

Stay on top of what we’re working on by subscribing to our email digest.

optional

Our Hottest Stories

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

Ryann Grochowski Jones is a data reporter at ProPublica. Previously, she was a data reporter for Investigative Newsource/KPBS in San Diego, Calif. She received her master’s degree from the University of Missouri School of Journalism, where she was a data librarian for Investigative Reporters and Editors/National Institute for Computer-Assisted Reporting. Ryann started her career as a municipal beat reporter for her hometown newspaper in Wilkes-Barre, Pa.

Articles

One Year, 2,000+ Downloads: Here’s How Our Data Store Is Doing

A year after we launched it, here’s what our Data Store looks like.

Uber Claims Credit for Drop in Drunk Driving Accidents. But Where’s the Evidence?

The ridesharing service published a report last week with Mothers Against Drunk Driving connecting the rise of Uber to a drop in drunk driving accidents. Except the connection isn't so clear.

Why Pharma Payments to Doctors Were So Hard to Parse

Flaws in information submitted to Open Payments, a government database of financial relationships in the medical field, complicated our analysis.

Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs

Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.

Methodology for Calculating Company Payments to Doctors

Even with new federal data, it's not easy to track drug, device company spending on their products

Open Payments Explorer: How Much Industry Money Goes to Doctors and Teaching Hospitals

Beginning in 2014, the federal government mandated that pharmaceutical and medical device manufacturers publicly report payments made to doctors and teaching hospitals. The first report covered the last five months of 2013. Use this tool to search for a company, drug or device.

Answering the Critics of our Deadly Force Story

We respond to arguments levied against our analysis of justified homicides by police officers.

As Controlled Substance Use Rises in Medicare, Prolific Prescribers Face More Scrutiny

Despite warnings about abuse, Medicare covered more prescriptions for potent controlled substances in 2012 than it did in 2011. The program's top prescribers often have faced disciplinary action or criminal charges related to their medical practices.

Big Changes in Fine Print of Some 2015 Obamacare Plans

A ProPublica analysis found that many health insurance plans offered in the federal Affordable Care Act marketplace are changing their benefits heading into 2015. Consumers have until Dec. 15 to switch plans before they are automatically re-enrolled.

Deadly Force, in Black and White

A ProPublica analysis of killings by police shows outsize risk for young black males.

What We’ve Learned From Four Years of Diving Into Dollars for Docs

Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 year alone. Here are our top five takeaways from following all that money.

How New York and Illinois Curb a Key Labor Violation While Other States Fall Short

The states have passed hard-nosed laws and taken an aggressive tack toward employers who misclassify independent contractors.

The Road to Health is Paved With Good Data

The nonprofit Health Data Consortium held its fifth-annual Health Datapalooza last week in Washington, D.C. Here are some highlights.

How We Analyzed Medicare Part B Data

We found some doctors who billed for the most costly, most complex visits almost exclusively and charged top rates far more than their peers.

Treatment Tracker

Use this tool to find and compare providers.

Top Billing: Meet the Docs who Charge Medicare Top Dollar for Office Visits

Medicare paid for more than 200 million office visits for established patients in 2012. Overall, health professionals classified only 4 percent as complex enough to command the most expensive rates. But 1,800 providers billed at the top level at least 90 percent of the time, ProPublica found.

Treatment Tracker Methodology

How we made a news app to compare doctors Medicare billing patterns.

Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their Research

Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analyzed. That raises questions about doctors’ impartiality.

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies will be required to report payments to doctors.

Introducing the ProPublica Data Store

Today we're launching a way to download and purchase our datasets.
Ryann Grochowski Jones

Contact Info

Get Updates

Stay on top of what we’re working on by subscribing to our email digest.

optional

Our Hottest Stories

  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •